positive
11 days agoWakefit, Corona Remedies IPOs See Rising GMP Ahead of Launch
Grey‑market premiums for the upcoming IPOs of Wakefit and Corona Remedies have climbed as much as 18–31% ahead of their subscription opening. Wakefit’s IPO (₹1,288 crore) is priced at ₹185–195 per share, while Corona Remedies’ offer (₹655 crore) comes at ₹1008–1062 per share. The rising GMP signals strong pre‑IPO demand and growing market optimism about their potential listing gains. Investors remain alert as the IPOs go live Monday.
Companies:
- Wakefit Innovations
- Corona Remedies Ltd
Tags:
- IPO
- Wakefit
Explore:Mutual Fund AI Screening
positive
11 days agoWakefit, Corona Remedies IPOs See Rising GMP Ahead of Launch
Grey‑market premiums for the upcoming IPOs of Wakefit and Corona Remedies have climbed as much as 18–31% ahead of their subscription opening. Wakefit’s IPO (₹1,288 crore) is priced at ₹185–195 per share, while Corona Remedies’ offer (₹655 crore) comes at ₹1008–1062 per share. The rising GMP signals strong pre‑IPO demand and growing market optimism about their potential listing gains. Investors remain alert as the IPOs go live Monday.
Companies:
- Wakefit Innovations
- Corona Remedies Ltd
Tags:
- IPO
- Wakefit
Recently
1 min read
69 words
GMPs for Wakefit and Corona Remedies IPOs jump up to ~31%, reflecting strong investor interest ahead of listing.
Grey‑market premiums for the upcoming IPOs of Wakefit and Corona Remedies have climbed as much as 18–31% ahead of their subscription opening. Wakefit’s IPO (₹1,288 crore) is priced at ₹185–195 per share, while Corona Remedies’ offer (₹655 crore) comes at ₹1008–1062 per share. The rising GMP signals strong pre‑IPO demand and growing market optimism about their potential listing gains. Investors remain alert as the IPOs go live Monday.
Grey‑market premiums for the upcoming IPOs of Wakefit and Corona Remedies have climbed as much as 18–31% ahead of their subscription opening. Wakefit’s IPO (₹1,288 crore) is priced at ₹185–195 per share, while Corona Remedies’ offer (₹655 crore) comes at ₹1008–1062 per share. The rising GMP signals strong pre‑IPO demand and growing market optimism about their potential listing gains. Investors remain alert as the IPOs go live Monday.
Companies:
- Wakefit Innovations
- Corona Remedies Ltd
Tags:
- IPO
- Wakefit
- IPO
- Wakefit
- Corona Remedies
- GMP
- market sentiment
Dec 4, 2025 • 10:41